Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis

Summary

The primary objective of this study is to demonstrate the efficacy of T1225 eye drops versus placebo eye drops on the global ocular discomfort (VAS).

Timeline

Start

2010-03

Primary completion

2012-06

Completion

2012-06

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Unifluid vs Azithromycin; p = 0.072; Mean Difference (Net) -8.01 (95% CI -16.30 to 0.28); Mixed Models Analysis NCT01089608 ↗

Drugs

Indications